Aug 12, 2020
Novo Ventures Portfolio Company F2G Closes US$60.8 Million Financing
Jun 10, 2020
F2G's Olorofim Receives Both FDA Orphan Drug Designation for Coccidioidomycosis (Valley Fever) and FDA QIDP Designation for Multiple Fungal Infections
Mar 09, 2020
F2G Receives US FDA Orphan Drug Designation for Olorofim
Feb 18, 2020
m8 Pharmaceuticals and Vectans Pharma signed an exclusive licensing agreement of Loramyc® (miconazole Lauriad®) for Mexico and Brazil
Feb 03, 2020
Global Invasive Fungal Infection (IFI) Market Report 2020 - Surging Demand for Low-Cost Pipeline Products, Increase in Use of Broad-Spectrum Antibiotics
Sep 09, 2019
FDA Grants Fast Track Status to Amplyx Pharmaceuticals for IV and Oral Formulations of Fosmanogepix (APX001) for Seven Different Indications
Jul 25, 2019
Information Update - Laser-based medical devices not authorized to treat fungal nail infections
Apr 08, 2019
F2G Appoints Dr. Patrick Vink as Chairman
Mar 14, 2019
SCYNEXIS Reports Full Year 2018 Financial Results and Provides Company Update
Feb 11, 2019
FDA Grants Orphan Drug Designation to Amplyx Pharmaceuticals for APX001 for Treatment of Cryptococcosis
Jan 30, 2019
SCYNEXIS Announces Positive Interim Results from Phase 3 Open-Label FURI Study, Showing Oral Ibrexafungerp's Ability to Treat Refractory Fungal Infections and to Provide an Alternative to Long-Term IV Therapies
Jan 07, 2019
F2G Expands Investor Syndicate and Progresses Phase 2b Study for Novel Antifungal
Nov 21, 2018
Blueberry Therapeutics Limited Announce Positive Results from a Phase I/II Clinical Trial
Nov 13, 2018
Amplyx Doses First Patient in Phase 2 Trial of APX001 in Patients with Candida Infection
Oct 15, 2018
InventHelp Inventor Develops CLOTRISONE (SAM-2593)
Oct 01, 2018
SCYNEXIS Supports AMR Challenge and Fungal Disease Awareness Week
Aug 14, 2018
Blueberry Therapeutics Limited Closes £10m Funding to Support Development of Nanomedicines Portfolio
Jul 18, 2018
The World Health Organization Recognizes New Antifungal Class by Granting "ibrexafungerp" to SCYNEXIS as the International Non-Proprietary Name for SCY-078
Jun 27, 2018
SCYNEXIS Announces the Presentation of SCY-078 Data at the Teratology Society 58th Annual Meeting
Jun 07, 2018
Amplyx Announces Presentations on APX001 at American Society for Microbiology Microbe 2018 and the 20th Symposium on Infections in the Immunocompromised Host